AlphaFold predicted structure
BCL10 · O95999

Mean pLDDT
69.5/ 100
Low
233 residues
Confidence breakdown
- Very high(≥ 90)35%
- Confident(70–90)11%
- Low(50–70)27%
- Very low(< 50)28%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
BCL10 immune signaling adaptor
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalimmunodeficiency 37
MALT lymphoma
testicular germ cell tumor
follicular lymphoma
diffuse large B-cell lymphoma
mesothelioma
lung carcinoma
multiple sclerosis
carcinoma of liver and intrahepatic biliary tract
T-cell acute lymphoblastic leukemia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
B-cell lymphoma/leukemia 10
Plays a key role in both adaptive and innate immune signaling by bridging CARD domain-containing proteins to immune activation (PubMed:10187770, PubMed:10364242, PubMed:10400625, PubMed:24074955, PubMed:25365219). Acts by channeling adaptive and innate immune signaling downstream of CARD domain-containing proteins CARD9, CARD11 and CARD14 to activate NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines (PubMed:24074955). Recruited by activated CARD domain-containing proteins: homooligomerized CARD domain-containing proteins form a nucleating helical template that recruits BCL10 via CARD-CARD interaction, thereby promoting polymerization of BCL10, subsequent recruitment of MALT1 and formation of a CBM complex (PubMed:24074955). This leads to activation of NF-kappa-B and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways which stimulate expression of genes encoding pro-inflammatory cytokines and chemokines (PubMed:18287044, PubMed:24074955, PubMed:27777308). Activated by CARD9 downstream of C-type lectin receptors; CARD9-mediated signals are essential for antifungal immunity (PubMed:26488816). Activated by CARD11 downstream of T-cell receptor (TCR) and B-cell receptor (BCR) (PubMed:18264101, PubMed:18287044, PubMed:24074955, PubMed:27777308). Promotes apoptosis, pro-caspase-9 maturation and activation of NF-kappa-B via NIK and IKK (PubMed:10187815)
BCL10 · O95999

Mean pLDDT
69.5/ 100
Low
233 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0